C0028429_NCI_EDQM-HC | Knowledge4COVID-19

Property	Value
?:definition	Relating to the nose as the intended site of administration, including where the pharmaceutical product is intended for local action in the nasal cavity or for systemic action after absorption through the mucous membrane; the lower respiratory tract is excluded.
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C0028429>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_EDQM-HC>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0028429_NCI_EDQM-HC>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0028429_NCI_EDQM-HC>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all